Poul Rødbroe Rasmussen
Corporate Officer/Principal chez Statens Serum Institute
Profil
Dr. Poul Rødbroe Rasmussen is Member-Institute Council at Statens Serum Institute.
He is on the Board of Directors at Bioneer A/S.
Dr. Rasmussen was previously employed as Chairman by LEO Pharma A/S and Chairman by LEO Fondet.
He also served on the board at MycoTeQ A/S.
He received his graduate degree from Technical University of Denmark and a doctorate degree from Technical University of Denmark.
Postes actifs de Poul Rødbroe Rasmussen
| Sociétés | Poste | Début |
|---|---|---|
| Statens Serum Institute | Corporate Officer/Principal | 19/06/2009 |
Anciens postes connus de Poul Rødbroe Rasmussen
| Sociétés | Poste | Fin |
|---|---|---|
LEO Pharma A/S
 LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Président | 31/12/2015 |
LEO Fondet
 LEO Fondet BiotechnologyHealth Technology LEO Fondet provides support for research in the fields of medicine, chemistry, and pharmacy. The company was founded on August 20, 1984 and is headquartered in Ballerup, Denmark. | Président | 31/12/2015 |
MycoTeQ A/S
 MycoTeQ A/S Pharmaceuticals: MajorHealth Technology MycoTeQ is working to ease the discovery process for the pharmaceutical industry in order to ensure a steady flow of new chemical entities into the pipelines of this industry. The aspiration of MycoTeQ is to build a healthy business and become the world leading external provider of new chemical entities from micro fungi. In order to succeed on these ambitious targets MycoTeQ will adhere to the highest professional and scientific standards and seek to build strong and long-lasting relationships with its partners and customers. The company was founded in October 2006 and is headquartered in Copenhagen, Denmark. | Directeur/Membre du Conseil | 02/04/2012 |
Bioneer A/S
 Bioneer A/S Pharmaceuticals: MajorHealth Technology Bioneer A/S develops and manufactures drugs. The firm's products and services drug development, molecular histology, dynamic gastric model, biomarkers and drug targets, protein manufacturing, mammalian cell technology, immune targeting, active ingredients and microorganisms. The company was founded in 2003 and is headquartered in Horsholm, Denmark. | Directeur/Membre du Conseil | - |
Formation de Poul Rødbroe Rasmussen
| Technical University of Denmark | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
LEO Pharma A/S
LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Health Technology |
Bioneer A/S
Bioneer A/S Pharmaceuticals: MajorHealth Technology Bioneer A/S develops and manufactures drugs. The firm's products and services drug development, molecular histology, dynamic gastric model, biomarkers and drug targets, protein manufacturing, mammalian cell technology, immune targeting, active ingredients and microorganisms. The company was founded in 2003 and is headquartered in Horsholm, Denmark. | Health Technology |
LEO Fondet
LEO Fondet BiotechnologyHealth Technology LEO Fondet provides support for research in the fields of medicine, chemistry, and pharmacy. The company was founded on August 20, 1984 and is headquartered in Ballerup, Denmark. | Health Technology |
MycoTeQ A/S
MycoTeQ A/S Pharmaceuticals: MajorHealth Technology MycoTeQ is working to ease the discovery process for the pharmaceutical industry in order to ensure a steady flow of new chemical entities into the pipelines of this industry. The aspiration of MycoTeQ is to build a healthy business and become the world leading external provider of new chemical entities from micro fungi. In order to succeed on these ambitious targets MycoTeQ will adhere to the highest professional and scientific standards and seek to build strong and long-lasting relationships with its partners and customers. The company was founded in October 2006 and is headquartered in Copenhagen, Denmark. | Health Technology |
